T1	Participants 129 210	patients with non-small-cell lung cancer after failure of first-line chemotherapy
T2	Participants 1292 1385	47 patients were randomized (median age: 60Â±8 years, PS 0/1/2: 44/83/20 patients; males: 78%)
